These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 2582706)
1. Alteration of zidovudine pharmacokinetics by probenecid in patients with AIDS or AIDS-related complex. de Miranda P; Good SS; Yarchoan R; Thomas RV; Blum MR; Myers CE; Broder S Clin Pharmacol Ther; 1989 Nov; 46(5):494-500. PubMed ID: 2582706 [TBL] [Abstract][Full Text] [Related]
2. Probenecid inhibits the metabolic and renal clearances of zidovudine (AZT) in human volunteers. Hedaya MA; Elmquist WF; Sawchuk RJ Pharm Res; 1990 Apr; 7(4):411-7. PubMed ID: 2362917 [TBL] [Abstract][Full Text] [Related]
4. A nonprimate animal model applicable to zidovudine pharmacokinetics in humans: inhibition of glucuronidation and renal excretion of zidovudine by probenecid in rats. Mays DC; Dixon KF; Balboa A; Pawluk LJ; Bauer MR; Nawoot S; Gerber N J Pharmacol Exp Ther; 1991 Dec; 259(3):1261-70. PubMed ID: 1762074 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of 3'-azido-3'-deoxythymidine and its catabolites and interactions with probenecid in rhesus monkeys. Cretton EM; Schinazi RF; McClure HM; Anderson DC; Sommadossi JP Antimicrob Agents Chemother; 1991 May; 35(5):801-7. PubMed ID: 1854160 [TBL] [Abstract][Full Text] [Related]
6. Influence of hemodialysis on zidovudine (AZT) and its glucuronide (GAZT) pharmacokinetics: two case reports. Garraffo R; Cassuto-Viguier E; Barillon J; Chanalet L; Lapalus P; Duplay H Int J Clin Pharmacol Ther Toxicol; 1989 Nov; 27(11):535-9. PubMed ID: 2613387 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic evaluation of drug interactions with anti-human immunodeficiency virus drugs. VI. Effect of the calcium channel blocker nimodipine on zidovudine kinetics in monkeys. Gallo JM; Swagler AR; Mehta M; Qian M J Pharmacol Exp Ther; 1993 Jan; 264(1):315-20. PubMed ID: 8423534 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic interaction between zidovudine and valproic acid in patients infected with human immunodeficiency virus. Lertora JJ; Rege AB; Greenspan DL; Akula S; George WJ; Hyslop NE; Agrawal KC Clin Pharmacol Ther; 1994 Sep; 56(3):272-8. PubMed ID: 7924122 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of oral ganciclovir alone and in combination with zidovudine, didanosine, and probenecid in HIV-infected subjects. Cimoch PJ; Lavelle J; Pollard R; Griffy KG; Wong R; Tarnowski TL; Casserella S; Jung D J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Mar; 17(3):227-34. PubMed ID: 9495222 [TBL] [Abstract][Full Text] [Related]
10. Effect of probenecid on the renal and nonrenal clearances of zidovudine and its distribution into cerebrospinal fluid in the rabbit. Hedaya MA; Sawchuk RJ J Pharm Sci; 1989 Sep; 78(9):716-22. PubMed ID: 2585262 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of zidovudine and dideoxyinosine alone and in combination in patients with the acquired immunodeficiency syndrome. Barry M; Howe JL; Ormesher S; Back DJ; Breckenridge AM; Bergin C; Mulcahy F; Beeching N; Nye F Br J Clin Pharmacol; 1994 May; 37(5):421-6. PubMed ID: 8054247 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of zidovudine in patients with liver cirrhosis. Taburet AM; Naveau S; Zorza G; Colin JN; Delfraissy JF; Chaput JC; Singlas E Clin Pharmacol Ther; 1990 Jun; 47(6):731-9. PubMed ID: 2357867 [TBL] [Abstract][Full Text] [Related]
13. Modulation of 3'-azido-3'-deoxythymidine catabolism by probenecid and acetaminophen in freshly isolated rat hepatocytes. Cretton EM; Sommadossi JP Biochem Pharmacol; 1991 Sep; 42(7):1475-80. PubMed ID: 1930271 [TBL] [Abstract][Full Text] [Related]
14. Acetaminophen does not impair clearance of zidovudine. Sattler FR; Ko R; Antoniskis D; Shields M; Cohen J; Nicoloff J; Leedom J; Koda R Ann Intern Med; 1991 Jun; 114(11):937-40. PubMed ID: 2024860 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic interaction of fluconazole and zidovudine in HIV-positive patients. Brockmeyer NH; Tillmann I; Mertins L; Barthel B; Goos M Eur J Med Res; 1997 Sep; 2(9):377-83. PubMed ID: 9300934 [TBL] [Abstract][Full Text] [Related]
16. Rapid and simultaneous determination of zidovudine and its glucuronide metabolite in plasma and urine. Application to the pharmacokinetic interaction of zidovudine and probenecid in the monkey. Qian MX; Finco TS; Gallo JM J Pharm Biomed Anal; 1991; 9(3):275-9. PubMed ID: 1908318 [No Abstract] [Full Text] [Related]
17. Azidothymidine steady-state pharmacokinetics in patients with AIDS and AIDS-related complex. Laskin OL; de Miranda P; Blum MR J Infect Dis; 1989 Apr; 159(4):745-7. PubMed ID: 2926164 [No Abstract] [Full Text] [Related]
18. Pharmacokinetic evaluation of drug interactions with zidovudine. I: Probenecid and zidovudine in monkeys. Qian MX; Finco TS; Mehta M; Viswanathan CT; Gallo JM J Pharm Sci; 1991 Nov; 80(11):1007-11. PubMed ID: 1815049 [TBL] [Abstract][Full Text] [Related]
19. Effects of standard breakfast on pharmacokinetics of oral zidovudine in patients with AIDS. Ruhnke M; Bauer FE; Seifert M; Trautmann M; Hille H; Koeppe P Antimicrob Agents Chemother; 1993 Oct; 37(10):2153-8. PubMed ID: 8257138 [TBL] [Abstract][Full Text] [Related]
20. Zidovudine disposition in patients with severe renal impairment: influence of hemodialysis. Singlas E; Pioger JC; Taburet AM; Colin JN; Fillastre JP Clin Pharmacol Ther; 1989 Aug; 46(2):190-7. PubMed ID: 2758728 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]